>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Monday 08 July 2024
08:30 - 09:30
Session 01: Keynote session
Monday 08 July 2024
08:30 - 09:30: Session 01: Keynote session:
Cornelis Lambalk, The Netherlands
08:30 - 09:00
Human Reproduction Keynote lecture: Progesterone for pregnant people with threatened miscarriage
09:00 - 09:30
CRISPR-Cas, from a bacterial defense system to a novel genetic tool in humans.
Raymond Staals, The Netherlands
09:30 - 10:30
Ziwig: Endometriosis 2.0 in the light of OMICS
09:30 - 10:30: Ziwig: Endometriosis 2.0 in the light of OMICS:
Towards a worldwide strategy to fight endometriosis
Is there a benefit of surgery for infertile patient with endometriosis?
Enda McVeigh, United Kingdom
What is the benefit of early diagnosis of endometriosis?
Sofiane Bendifallah, France
Caterina Exacoustos, Italy
09:30 - 10:00
Coffee break in the exhibit hall
09:30 - 10:00: Coffee break in the exhibit hall:
10:00 - 11:30
Session 02: The key players for success: the gametes
10:00 - 11:30: Session 02: The key players for success: the gametes:
Gemma Arroyo Cardona, Spain
Dorit Christina Kieslinger, The Netherlands
10:00 - 10:15
COC classifier: a new artificial intelligence-based tool for identifying mature oocytes from cumulus- oocyte-complexes.
Israel Maldonado Rosas, Mexico
10:15 - 10:30
Oocyte image assessment by novel artificial intelligence (AI) model predicts blastocyst PGT-A results, outperforming age as a predictor
10:30 - 10:45
The in vitro maturation rate of human oocytes is enhanced following uptake of extracellular vesicles derived from mature follicles
Sofia Makieva, Switzerland
10:45 - 11:00
Oocyte factors as predictors of abnormal, mononucleated and trinucleated, zygotes and assessment of their morphokinetic differences.
Jose Luis De Pablo Franco, Spain
11:00 - 11:15
Leveraging warning thresholds of oocyte immaturity rate to identify patients at risk of pathological endophenotypes. Analysis of 16,155 retrievals with implications for rescue-IVM.
11:15 - 11:30
Sperm-derived centrioles play a key role in ensuring correct chromosome segregation in the first mitotic division of mammalian zygotes
Ainhoa Larreategui, The Netherlands
10:00 - 11:30
Session 03: Smarter strategies to optimal ovarian stimulation - time to rethink (part 1)
10:00 - 11:30: Session 03: Smarter strategies to optimal ovarian stimulation - time to rethink (part 1):
Femke Mol, The Netherlands
10:00 - 10:15
Comparison of the flexible Progestin-Primed Ovarian Stimulation with the GnRH antagonist protocol in predicted suboptimal responders: a freeze-all randomized controlled trial
10:15 - 10:30
Luteal estradiol versus follicular GnRH antagonist for ovarian follicular synchronization in POSEIDON poor responders: A multicentric randomized controlled trial
10:30 - 10:45
Is there a need for LH surge inhibition by GnRH-antagonists in luteal phase stimulation in poor ovarian responders undergoing Duostim? Efficacy of natural progesterone.
10:45 - 11:00
Three Injections Protocol for IVF; a proof of concept study into elaborating the outmost patient friendly protocol in IVF
Evangelos Papanikolaou, Greece
11:00 - 11:15
Population pharmacokinetics of follitropin delta during ovarian stimulation
11:15 - 11:30
Cumulative live birth associated with number of oocytes in ovarian stimulation with follitropin delta: an individual patient data meta-analysis.
Ida Engberg Jepsen, Denmark
10:00 - 11:30
Session 04: How to improve sperm quality for ART?
10:00 - 11:30: Session 04: How to improve sperm quality for ART?:
Michael Carroll, United Kingdom
Liliana Ramos, The Netherlands
10:00 - 10:15
Enabling laboratory-quality male fertility analysis with 72-hour post-ejaculation sample viability
10:15 - 10:30
To be or not to be capacitated after sperm preparation: tyrosine phosphorylation as predictive indicator for capacitation status and male fertility potential
Ana Ortiz Vallecillo, Spain
10:30 - 10:45
Swim-up versus density gradients for sperm preparation in intrauterine insemination: a multi-centre randomised clinical trial
10:45 - 11:00
Utilisation of second successive ejaculate as a way to overcome poor semen parameters for couples who wish to undergo conventional-IVF
Panagiota Tsounapi, Japan
11:00 - 11:15
Outcomes and correlations between traditional Intracytoplasmic Sperm Injection (ICSI) method and a new AI-enhanced system
Dimitrios Mantas, United Arab Emirates
11:15 - 11:30
Investigating the effect of advanced sperm preparation techniques on embryo developmental potential and clinical outcomes: A network meta-analysis of Randomized Controlled Trials
10:00 - 11:30
Session 05: Imaging of endometriosis and endometrial disorders: roads to the future
10:00 - 11:30: Session 05: Imaging of endometriosis and endometrial disorders: roads to the future:
Velja Mijatovic, The Netherlands
10:00 - 10:15
Magnetic Resonance Imaging (MRI) evaluation of Quinagolide Vaginal Ring (QVR) treatment on endometrioma, Deep Infiltrating Endometriosis (DIE), and adenomyosis lesion characteristics: QLARITY trial results
10:15 - 10:30
Early tubal flushing with oil-based contrast during hysterosalpingography versus no tubal flushing in women with unexplained infertility – H2Oil-timing randomized controlled trial
Danah Kamphuis, The Netherlands
10:30 - 10:45
Does flushing with oil-based contrast during hysterosalpingography (HSG) increase the live birth rate as compared to water-based contrast: A prospective cohort study
10:45 - 11:00
Age affects ultrasound markers of endometrial receptivity in artificial cycles
11:00 - 11:15
An artificial intelligence (AI) model non-invasively evaluates endometrial receptivity from ultrasound images, surpassing endometrial thickness (EMT) in predicting implantation
11:15 - 11:30
Development of deep learning-based model for differential diagnosis of ovarian neoplasm using pelvic ultrasonography
Yeon Hee Hong, Korea, South
10:00 - 11:30
Session 06: Therapeutic concepts in implantation and early pregnancy
10:00 - 11:30: Session 06: Therapeutic concepts in implantation and early pregnancy:
Lisa Lashley, The Netherlands
10:00 - 10:15
Efficacy results from the phase II randomized clinical trial: OXO-001 in infertile women undergoing egg donation IVF/ICSI
10:15 - 10:30
DNA methylation testing with cervical secretion can serve as a non-invasive biomarker for predicting successful implantation in frozen-thawed embryo transfer
Chii-Ruey Tzeng, Taiwan R.O.C.
10:30 - 10:45
Atosiban in women with previous single implantation failure undergoing frozen-thawed blastocyst transfer: A placebo-controlled randomized trial
10:45 - 11:00
The impact of aneuploidy on human peri-implantation development: findings from the extended in vitro culture of 191 human embryos
11:00 - 11:15
Tacrolimus treatment significantly improved IVF outcomes with euploid embryo transfer in women with repeated implantation failures (RIF) and elevated T helper (Th)1/Th2 cell ratios
11:15 - 11:30
Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss undergoing assisted reproductive technology treatment: a randomized, double-blinded, placebo-controlled trial.
Caroline Nørgaard-Pedersen, Denmark
10:00 - 11:30
Session 07: Genetic frontiers: new insights in gamete and embryo research
10:00 - 11:30: Session 07: Genetic frontiers: new insights in gamete and embryo research:
Esther Baart, The Netherlands
10:00 - 10:15
Molecular insights into the decline in oocyte quality with advanced maternal age: findings from comprehensive single cell -omics analysis of 112 human oocytes
Styliani Galatidou, Ireland
10:15 - 10:30
Specific kir gene profiles and recurrent implantation failure
10:30 - 10:45
Euploidy's hidden potential: Emerging insights from abnormal fertilized embryos
Balsam Al Hashimi, United Kingdom
10:45 - 11:00
How much DNA is shared between a human egg and each of the polar bodies? Theory and genomic data from polar bodies and triploid embryos
11:00 - 11:15
An update on the genetics of dizygotic twinning
Dorret Boomsma, The Netherlands
11:15 - 11:30
Impact of maternal aging on the DNA repair landscape in mouse oocytes
10:00 - 11:30
Session 08: Poster discussion session - SQART
10:00 - 11:30: Session 08: Poster discussion session - SQART:
Aleksej Stevanovic, Norway
10:00 - 10:15
Preselected for an award: Congenital heart defects in children born after assisted reproductive technology: A large cohort study from the Committee of Nordic Assisted Reproductive Technology and Safety (CoNARTaS)
10:15 - 10:30
A decade of transformations in IVF strategies towards enhanced clinical efficacy, efficiency, and safety: the real-life experience of 6610 couples
10:30 - 10:45
Preselected for an award: Association between ovarian hyperstimulation syndrome and adverse obstetric and neonatal outcomes in Korea: a nationwide health insurance database study
Yunjeong Park, Korea, South
10:45 - 11:00
Exploration of maternal proteome over pregnancy based on corpus luteum number at conception
Frauke von Versen-Höynck, Germany
11:00 - 11:15
GLP-1 receptor agonist treatment in early pregnancy and risk of pregnancy complications - A nationwide cohort study
11:15 - 11:30
Twin births in Belgium: a national cohort analysis of 35 523 double fresh embryo transfers between 2012 and 2021
11:15 - 12:15
Theramex: Exploring the Role of dydrogesterone in Luteal Phase Support: Optimizing its use for Successful Implantation
11:15 - 12:15: Theramex: Exploring the Role of dydrogesterone in Luteal Phase Support: Optimizing its use for Successful Implantation:
Is dydrogesterone the new standard of care in fresh cycle IVF?
Christophe Blockeel, Belgium
What is the fetal safety profile of dydrogesterone usage in ART?
Alexander Katalinic, Germany
How can dydrogesterone optimize FET cycle performance and outcomes?
Georg Griesinger, Germany
11:45 - 13:00
Ferring Pharmaceuticals:Follitropin Delta: A 10-year data driven journey
11:45 - 13:00: Ferring Pharmaceuticals:Follitropin Delta: A 10-year data driven journey:
A decade of transformation: Evolution in Reproductive Medicine
Ying Cheong, United Kingdom
11:55 - 12:10
Unraveling follitropin delta: Rigorous RCT programs for clinical development
Bart C.J.M. Fauser, The Netherlands
12:10 - 12:30
Exploring the depths: Insights from post-hoc analyses and meta-analyses in RCT repositories
Samuel Dos Santos-Ribeiro, Portugal
12:30 - 12:45
Translating to clinical practice: Validating trial findings in a real-world setting
Christophe Blockeel, Belgium
12:45 - 12:55
Future trajectories: Unveiling the path forward in follitropin delta research
12:55 - 13:00
Thank you and closing remarks
Ying Cheong, United Kingdom
11:45 - 12:45
Session 09: Debate: Late o’clock: are slow growing embryos clinically usable?
11:45 - 12:45: Session 09: Debate: Late o’clock: are slow growing embryos clinically usable?:
Ieva Masliukaite, The Netherlands
11:45 - 12:00
Con - the faster the better
12:00 - 12:15
Pro - better late than never
11:45 - 12:15
Session 10: Data reporting session
11:45 - 12:15: Session 10: Data reporting session:
Alwin Aha Derijck, The Netherlands
11:45 - 12:15
Data from the ESHRE PGT Consortium - year 2022
Francesca Spinella, Italy
11:45 - 12:45
Session 11: Debate: Dual and/or double trigger improve IVF success
11:45 - 12:45: Session 11: Debate: Dual and/or double trigger improve IVF success:
Nikolaos P. Polyzos, Spain
Joop Laven, The Netherlands
11:45 - 12:45
Session 12: ASRM Exchange session: Assisted reproductive technologies: new horizons
11:45 - 12:45: Session 12: ASRM Exchange session: Assisted reproductive technologies: new horizons:
Elizabeth Ginsburg, U.S.A.
11:45 - 12:00
The promise and peril of germline gene therapy
12:05 - 12:20
Does PGT improve outcomes in poor responders?
Elizabeth Ginsburg, U.S.A.
12:25 - 12:40
Fertility preservation in the male across the lifespan: A new paradigm
Robert E. Brannigan, U.S.A.
11:45 - 12:45
Session 13: Live Journal Club: Good practice recommendations on add-ons in reproductive medicine
11:45 - 12:45: Session 13: Live Journal Club: Good practice recommendations on add-ons in reproductive medicine:
Munevver Serdarogullari, Cyprus
Omar Ammar, United Kingdom
11:50 - 11:55
Paper presentation
Mina Mincheva, United Kingdom
11:55 - 12:00
Introduction of experts and moderators
Omar Ammar, United Kingdom
12:00 - 12:45
Main discussion
Ioannis Sfontouris, Greece
Nicholas Macklon, United Kingdom
Co-speaker[0000786160] Main discussion
Manuela Perrotta, United Kingdom
Cornelis Lambalk, The Netherlands
11:45 - 12:45
Session 14: Poster discussion session - Stem cells
11:45 - 12:45: Session 14: Poster discussion session - Stem cells:
11:45 - 12:00
Preselected for an award: Engineering Vascularized Human Endometrial Organoids for In Vivo Tissue Regeneration and Repair Applications
12:00 - 12:15
Preselected for an award: Heritable genome editing in haploid mouse embryonic stem cells
12:15 - 12:30
Trophoblast organoids as a 3D model for the study of oxygen concentration during in vitro preimplantation embryo culture
12:30 - 12:45
Assessment of embryo development following fertilization with de novo male gametes generated in a three-dimensional culture
13:00 - 14:00
Lunch break in the exhibit hall
13:00 - 14:00: Lunch break in the exhibit hall:
13:00 - 14:00
Thermo Fisher Scientific: Innovation and trends in reproductive health genetic testing
13:00 - 14:00: Thermo Fisher Scientific: Innovation and trends in reproductive health genetic testing:
13:00 - 13:03
Welcome note
13:03 - 13:15
Delivering premium PGT add-ons to go beyond classic PGT
13:15 - 13:27
Demystifying PGTA: invasive vs niPGTA
13:27 - 13:39
Coelocentesis and fetal health. Chromosome aneuploidies and monogenic disorders
Salvatore A. Longo, Italy
14:00 - 15:15
Gedeon Richter: Unveiling the Realms of Reproduction: A Comprehensive Dive into Modern Oocyte Assessment
14:00 - 15:15: Gedeon Richter: Unveiling the Realms of Reproduction: A Comprehensive Dive into Modern Oocyte Assessment:
David K. Gardner, Australia
Laura Francesca Rienzi, Italy
14:00 - 14:15
Exploring Lifestyle's patterns in Shaping Oocyte Destiny
Helen O'Neill, United Kingdom
14:15 - 14:30
Mapping Oocyte Morphology's Influence on Clinical Outcomes
14:30 - 14:40
Navigating the Contemporary Landscape of Oocyte Quality.
14:40 - 14:50
Decoding the Essential Indications in Oocyte Quality Assessment.
14:50 - 15:15
Panel discussion
14:00 - 15:00
Session 15: Endometriosis associated infertility
14:00 - 15:00: Session 15: Endometriosis associated infertility:
Christian Becker, United Kingdom
Annemiek Nap, The Netherlands
14:00 - 14:20
Understanding endometrial functionality and embryo-maternal communication via in vitro ‘’OMICs’’ platforms
Susana M. Chuva de Sousa Lopes, The Netherlands
14:30 - 14:50
Can we tailor ART to endometriosis patients?
Velja Mijatovic, The Netherlands
14:00 - 15:00
Session 16: New identified genetic causes of female infertility
14:00 - 15:00: Session 16: New identified genetic causes of female infertility:
Ron Van Golde, The Netherlands
14:00 - 14:20
Newly identified female mutations causing failed fertilization
Arantxa Cardona Barberán, Belgium
14:30 - 14:50
Newly identified female mutations causing oocyte maturation defect and embryo developmental arrest
14:00 - 15:00
Session 17: IFS/ISAR Exchange session: The ovary
14:00 - 15:00: Session 17: IFS/ISAR Exchange session: The ovary:
Sunita Tandulwadkar, India
14:00 - 14:12
ART in PCOS
Rishma Dhillon Pai, India
14:15 - 14:27
Ovarian rejuvenation - fact or fiction?
14:30 - 14:42
Ovarian cancer and fertility - current understanding
14:45 - 14:57
New strategies in ovarian stimulation
14:00 - 15:00
Session 18: Embryo "correction" mode to maximize success
14:00 - 15:00: Session 18: Embryo "correction" mode to maximize success:
Carlijn Vergouw, The Netherlands
14:00 - 14:15
How does the exclusion of blastomeres affect the outcome of euploid blastocysts?
Hakan Kadir Yelke, Turkey
14:15 - 14:30
Can artificial removal of the zona pellucida with severe fragmentation improve culture and pregnancy outcomes?
14:30 - 14:45
PGT-A reveals triploid embryos among normally fertilized oocytes: Frequency and blastocyst features.
14:45 - 15:00
Parental inheritance of monopronuclear blastocysts from ICSI cycles and its association with specific morphokinetic traits: a retrospective observational study
14:00 - 15:00
Session 19: International Reproductive Health Education Collaboration (IRHEC) – An update
14:00 - 15:00: Session 19: International Reproductive Health Education Collaboration (IRHEC) – An update:
Bola Grace, United Kingdom
14:00 - 14:20
An update from the international reproductive health education collaboration.
Joyce Harper, United Kingdom
14:30 - 14:50
Educating young people about reproductive health.
Rina Biswakarma, United Kingdom
14:00 - 15:00
Session 20: Poster discussion session - Fetility preservation
14:00 - 15:00: Session 20: Poster discussion session - Fetility preservation:
Claudia Massarotti, Italy
14:00 - 14:15
Preselected for an award: The age-associated increase in ovarian stiffness compromises follicle development and induces changes in the follicles’ transcriptome, resulting in poor-quality oocytes
14:15 - 14:30
Autologous cryopreserved ovarian tissue transplantation and perinatal outcomes: a systematic review with pooled analysis
14:30 - 14:45
Recombinant human anti-Müllerian hormone reduces doxorubicin-induced reproductive aging by regulating Id3 expression and promoting DNA repair
Eun Mi Chang, Korea, South
14:45 - 15:00
Fertility outcomes several years after fertility preservation for endometriosis
Rebecca Goldstein, France
14:45 - 15:45
CooperSurgical: Up Close and Personal with Alviggi and Campbell - Treatment Options: Evidence and Insights for Clinic and Lab
14:45 - 15:45: CooperSurgical: Up Close and Personal with Alviggi and Campbell - Treatment Options: Evidence and Insights for Clinic and Lab:
Alison Campbell, United Kingdom
15:15 - 16:30
Session 21: Intersecting pathways: genetics, proteins, and embryology
15:15 - 16:30: Session 21: Intersecting pathways: genetics, proteins, and embryology:
Giovanni Coticchio, Italy
Edith Coonen, The Netherlands
15:15 - 15:30
The first mitotic spindle instability impacts nucleation, fragmentation, and development in human embryos
15:30 - 15:45
Cas9-based chromosome labelling reveals large-scale age-dependent centromere reorganisation in human oocytes
Aleksandra Byrska, United Kingdom
15:45 - 16:00
Stringent statistical analysis of 108,684 oocyte donation cycles identifies 2.6% of donors with specific oocyte/embryo developmental arrest phenotypes for genome association studies.
Christian Simon Ottolini, United Kingdom
16:00 - 16:15
The canonical Hippo signalling pathway controls the first lineage segregation in the human preimplantation embryo
Panagiotis Stamatiadis, Belgium
16:15 - 16:30
CD163 in follicular fluids can be the novel marker to predict clinical outcome of oocyte.
15:15 - 16:30
Session 22: It all starts with the egg - updates and new advances
15:15 - 16:30: Session 22: It all starts with the egg - updates and new advances:
Tom Adriaenssens, Belgium
Madelon Van Wely, The Netherlands
15:15 - 15:30
Dual trigger is not superior to GnRH Agonist alone for final oocyte maturation in elective fertility preservation. A Randomized Controlled Trial.
15:30 - 15:45
Particulate matter (PM2.5 and PM10) exposure prior to oocyte collection is associated with decreased live birth rates in subsequent frozen embryo transfers
Sebastian Leathersich, Spain
15:45 - 16:00
Novel method to enhance preantral follicle growth by granulocyte colony-stimulating factor administration improves embryos and pregnancy rate in poor ovarian reserve: a randomized controlled trial
16:00 - 16:15
Depletion of MFF from oocytes impairs mitochondrial dynamics, leading to inhibited oocyte maturation and early embryonic development in mice
16:15 - 16:30
Deletion of interlukin-17A protects against ovarian aging via activating wnt10b/β-catenin signaling
15:15 - 16:30
Session 23: Novel insights on psychosocial outcomes
15:15 - 16:30: Session 23: Novel insights on psychosocial outcomes:
Mariana Sousa Leite, United Kingdom
15:15 - 15:30
Reflecting on the fertility journey: Insights from couples who discontinued fertility treatment without giving birth
Laurie Beauvilliers, Canada
15:30 - 15:45
The effect of psychosocial support on motivation for assisted reproductive treatments
Judit Szigeti F., Hungary
15:45 - 16:00
Navigating the crossroads: Unraveling predictors for treatment discontinuation in couples pursuing assisted reproduction: Findings from a 2-year prospective study
Katherine Péloquin, Canada
16:00 - 16:15
From words to wellness: a retrospective study leveraging large language models on conversational data to uncover patient needs
16:15 - 16:30
Sexual function in women with Premature Ovarian Insufficiency (POI): systematic review and meta-analysis
Charissa van Zwol - Janssens, The Netherlands
15:15 - 16:30
Session 24: Female fertility preservation - focus on outcomes
15:15 - 16:30: Session 24: Female fertility preservation - focus on outcomes:
Mariette Goddijn, The Netherlands
15:15 - 15:30
Outcomes of female fertility preservation with cryopreservation of oocytes or embryos: a population-based study
Elena ter Welle - Butalid, The Netherlands
15:30 - 15:45
Oocyte cryopreservation: a comprehensive analysis of live birth rate by age and indication of treatment provides reassurance for young cancer patients.
Michal Kirshenbaum, Australia
15:45 - 16:00
Risk of serious adverse event after fertility preservation procedures: a comparison of cancer and non-cancer patients
16:00 - 16:15
Use and safety of assisted reproductive technology in young BRCA carriers with a pregnancy after treatment for breast cancer: results from an international cohort study
Isotta Martha Magaton, Switzerland
16:15 - 16:30
Effect of low, medium and high risk chemotherapy on the ovarian reserve in children: results of the interim analysis of a prospective multicentric trial (CHANCE)
Isabelle Demeestere, Belgium
15:15 - 16:30
Session 25: The alpha and omega of safety and quality in ART
15:15 - 16:30: Session 25: The alpha and omega of safety and quality in ART:
Charine van Tilborg, The Netherlands
15:15 - 15:30
Association of pituitary suppression method with euploid blastocyst yield in preimplantation genetic testing for aneuploidy (PGT-A) cycles
15:30 - 15:45
The paradox of choice in double (DET) versus single (SET) embryo transfer: more is less!
Jan-Steffen Krüssel, Germany
15:45 - 16:00
Severe maternal and neonatal morbidity among gestational carriers: a population-based cohort study
16:00 - 16:15
Prevalence of multiple gestation births and perinatal outcomes in pregnancies secondary to clomiphene citrate treatment: a nationwide cohort study
16:15 - 16:30
Infant mortality after assisted reproductive technology – a Nordic collaborative study on 7,947,575 liveborn children
15:15 - 16:30
Session 26: Advances and challenges in modeling human reproduction
15:15 - 16:30: Session 26: Advances and challenges in modeling human reproduction:
Susana M. Chuva de Sousa Lopes, The Netherlands
15:15 - 15:30
Novel stem cell-based twin embryo model reveals inner cell mass division and enhanced endometrial adhesion in monochorionic twin development.
Erik Vrij, The Netherlands
15:30 - 15:45
Assessment of genome editing outcomes in human preimplantation embryos subjected to CRISPR-Cas9 – most loss of heterozygosity (LOH) events are caused by DNA repair deficiency
Nada Kubikova, United Kingdom
15:45 - 16:00
Human fallopian tube organoids provide a favorable environment for sperm motility
16:00 - 16:15
Implantation-on-chip: precise quantification for functional implantation failure studies
16:15 - 16:30
The transcriptome of endometrial organoids of fertile and subfertile women exposed to seminal plasma of fertile men
Jonna van den Berg, The Netherlands
15:15 - 16:30
Session 27: Poster discussion session - Implantation and early pregnancy
15:15 - 16:30: Session 27: Poster discussion session - Implantation and early pregnancy:
15:15 - 15:30
Preselected for an award: Monozygotic twins from in vitro fertilization: can bring the rate closer to that of natural conception?
15:30 - 15:45
Comparison of luteal support protocols in fresh IVF/ICSI cycles: A network meta-analysis.
Stavroula Lila Kastora, United Kingdom
15:45 - 16:00
Preselected for an award: Non-autologous human platelet lysate as a therapy for recurrent implantation failure: lessons from in vitro models
Tina Tu-Thu Ngoc Nguyen, Canada
16:00 - 16:15
Lower ectopic pregnancy prevalence with natural endometrial preparation in single euploid frozen embryo transfers
Raquel Del Gallego, United Arab Emirates
16:15 - 16:30
Perinatal outcomes after recurrent pregnancy loss: a systematic review and meta-analysis
Isabelle Letourneau, Canada
16:30 - 17:00
Coffee break in the exhibit hall
16:30 - 17:00: Coffee break in the exhibit hall:
17:00 - 18:15
IBSA: Adenomyosis in ART: uncharted territory
17:00 - 18:15: IBSA: Adenomyosis in ART: uncharted territory:
Dominique De Ziegler, France
17:00 - 17:05
Welcome and introduction
17:05 - 17:25
Diagnosing of adenomyosis: ultrasound, MUSA criteria and MRI
Caterina Exacoustos, Italy
17:25 - 17:45
Adenomyosis in the clinic: symptomatic or asymptomatic
17:00 - 18:00
Session 28: Implantation update from research and practice
17:00 - 18:00: Session 28: Implantation update from research and practice:
Antonis Makrigiannakis, Greece
Merel van den Berg, The Netherlands
17:00 - 17:20
Implantation 2024 - What do we know?
Siobhan Quenby, United Kingdom
17:30 - 17:50
Chronic endometritis - Research and practice
17:00 - 18:00
Session 29: DNA damage in gametes: origin, repair and clinical relevance
17:00 - 18:00: Session 29: DNA damage in gametes: origin, repair and clinical relevance:
Frank J. Broekmans, The Netherlands
17:00 - 17:20
From spermatozoa to embryos
17:30 - 17:50
From oocytes to embryos
17:00 - 18:00
Session 30: Family size in ART
17:00 - 18:00: Session 30: Family size in ART:
Yvonne Louwers, The Netherlands
The challenge of European populations: between low and late fertility, aging and growing migration flow
Gianpiero Dalla Zuanna, Italy
17:30 - 17:50
Contribution of ART to fertility rates and family size
Georgina Chambers, Australia
17:00 - 18:00
Session 31: Fertility awareness from childhood to adulthood
17:00 - 18:00: Session 31: Fertility awareness from childhood to adulthood:
Valerie Blanchet De Mouzon, France
Sarah Michon, The Netherlands
17:00 - 17:15
The FERTILITAS study: exploring parenthood intentions among reproductive-aged individuals without children in Belgium
Eva Van Steijvoort, Belgium
17:15 - 17:30
The contribution of women's modes of conception, self-mastery, perceived stress, and cognitive appraisal to personal growth in two phases during pregnancy
Elad Mijalevich-Soker, Israel
17:30 - 17:45
Acceptance rates and reasons for social oocyte cryopreservation among women: systematic review and meta-analysis
İlkay Güngör Satılmış, Turkey
17:45 - 18:00
Reproductive health education: collaborative design of a learning platform for secondary school education involving reproductive health experts, pupils, and teachers
17:00 - 18:30
Session 32: Guidelines session: ESHRE Guidelines for clinicians
17:00 - 18:30: Session 32: Guidelines session: ESHRE Guidelines for clinicians:
Richard Anderson, United Kingdom
Annemieke Hoek, The Netherlands
17:00 - 17:20
Premature ovarian insufficiency: new data and updated guidance
Nick Panay, United Kingdom
17:30 - 17:50
ESGO / ESHRE / ESGE Guidelines for the fertility sparing treatment & follow-up in gynecological cancers
17:00 - 18:00
Session 33: Poster discussion session - Psychology & counselling
17:00 - 18:00: Session 33: Poster discussion session - Psychology & counselling:
Mariana Moura-Ramos, Portugal
17:00 - 17:15
The experiences and outcomes of donor conceived adults in the UK who are actively searching, open to contact with, and not searching for donor connections
Sophie Zadeh, United Kingdom
17:15 - 17:30
Multicentre two-arm randomised controlled trial of Beyond Fertility: A brief face-to-face psychosocial intervention to promote patients’ healthy adjustment when ending unsuccessful fertility treatment
Mariana Sousa Leite, United Kingdom
17:30 - 17:45
Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome
Tamara Jannink, The Netherlands
17:45 - 18:00
Infertility stigma, openness with others, and their relationship to depression and meaning in life among men and women experiencing infertility
08:00 - 18:00
IFFS Committee meeting
08:00 - 18:00: IFFS Committee meeting:
09:00 - 10:00
ESHRE 2025 - LOC
09:00 - 10:00: ESHRE 2025 - LOC:
09:00 - 11:00
PGT Steering Comittee meeting
09:00 - 11:00: PGT Steering Comittee meeting:
10:00 - 12:00
OS update guideline meeting
10:00 - 12:00: OS update guideline meeting:
09:30 - 17:00
Fertility Europe meeting
09:30 - 17:00: Fertility Europe meeting:
11:00 - 12:00
ESHRE-ALMER meeting
11:00 - 12:00: ESHRE-ALMER meeting:
12:00 - 14:00
Human Reproduction Associate Editors' meeting
12:00 - 14:00: Human Reproduction Associate Editors' meeting:
12:00 - 14:00
Molecular Human Reproduction Associate Editors' meeting
12:00 - 14:00: Molecular Human Reproduction Associate Editors' meeting:
12:00 - 14:00
ICMART Contributors meeting
12:00 - 14:00: ICMART Contributors meeting:
12:00 - 14:00
EMCC Committee meeting Part 2
12:00 - 14:00: EMCC Committee meeting Part 2:
12:00 - 14:00
Good practice recommendation on Expanded Carrier Screening meeting
12:00 - 14:00: Good practice recommendation on Expanded Carrier Screening meeting:
12:30 - 14:00
Ethics in PGT - writing group
12:30 - 14:00: Ethics in PGT - writing group:
13:00 - 14:00
ESHRE Committee of National Representatives meeting
13:00 - 14:00: ESHRE Committee of National Representatives meeting:
13:00 - 15:00
PGT Consortium General Assembly meeting
13:00 - 15:00: PGT Consortium General Assembly meeting:
14:00 - 15:30
ATCRM meeting
14:00 - 15:30: ATCRM meeting:
14:00 - 16:30
NMCC Committee meeting Part 1
14:00 - 16:30: NMCC Committee meeting Part 1:
14:30 - 16:30
FP in boys and adolescent males guideline meeting
14:30 - 16:30: FP in boys and adolescent males guideline meeting:
15:00 - 16:00
ESHRE-IFS/ISAR meeting
15:00 - 16:00: ESHRE-IFS/ISAR meeting:
15:00 - 17:00
Focus group between "Stem Cells" and "Ethics and Law" meeting
15:00 - 17:00: Focus group between "Stem Cells" and "Ethics and Law" meeting:
15:30 - 17:00
EIM Steering Committee meeting
15:30 - 17:00: EIM Steering Committee meeting:
16:15 - 17:00
CSAO/FSANZ Award Committee meeting
16:15 - 17:00: CSAO/FSANZ Award Committee meeting: